MSB 4.66% $1.13 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-1017

  1. 5,655 Posts.
    lightbulb Created with Sketch. 2035
    They don't have to tell us everything. As others have pointed out here, there are competitive reasons for them to hold their data very tightly.

    They have previously indicated that data from the Covid trial might be useful for the GVHD application.

    https://hotcopper.com.au/posts/53299352/single


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.055(4.66%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.18 $1.18 $1.13 $4.824M 4.236M

Buyers (Bids)

No. Vol. Price($)
2 25589 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 10000 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.